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Subcellular organellesExpression and activity of the Ste20-like kinase, SLK, are increasedduringkidney development and recovery from
ischemia–reperfusion injury. SLK mediates apoptosis in various cells, and can regulate cell cycle progression and
cytoskeletal remodeling. In cells, SLK is detected in a high molecular mass complex, suggesting that SLK is a
dimer/oligomer, or is in tight association with other proteins. To better understand the regulation, localization
and function of SLK, we sought to identify proteins in this high molecular mass complex. Analysis by mass
spectroscopy identiﬁed the nucleoporin, translocated promoter region (Tpr), and the cytoskeletal protein,
α-actinin-4, as potential SLK-interacting proteins. Using a protein complementation assay, we showed that the
350 amino acid C-terminal, coiled-coil domain of SLK was responsible for homodimerization, as well as interac-
tion with Tpr and α-actinin-4. The association of SLK with Tpr and α-actinin-4, respectively, was conﬁrmed by
co-immunoprecipitation. Subsets of total cellular SLK colocalized with Tpr at the nuclear envelope, and
α-actinin-4 in the cytoplasm. Expression of Tpr attenuated activation-speciﬁc autophosphorylation of SLK, and
blocked SLK-induced apoptosis and AP-1 activity. In contrast to the effect of Tpr, autophosphorylation of SLK
was not affected byα-actinin-4. Thus, SLK interacts with Tpr and α-actinin-4 in cells, and these protein–protein
interactions may control the subcellular localization and the biological activity of SLK.
© 2015 Elsevier B.V. All rights reserved.1. Introduction
Ste20-like kinase, SLK, is a serine/threonineprotein kinase belonging
to the group ﬁve germinal center kinase (GCK) family [1–3]. Similarly to
the other members of the GCK family, SLK is reported to be a mitogen-
activated protein kinase kinase kinase kinase (MAP4K), and SLK can
activate certain MAPK signaling cascades. Although a number of studies
have addressed the signaling pathways activated by SLK and other GCK
family members, the physiological role of this family of kinases remains
poorly understood.
Several studies revealed a role for SLK in the regulation of apoptosis
and cytokinesis. Sabourin and Rudnicki ﬁrst characterized SLK as a
mediator of apoptosis in ﬁbroblasts [3–5]. Furthermore, expression
and activity of SLKwere enhanced in renal ischemia–reperfusion injury,
and overexpression of SLK was shown to induce apoptosis in cultured
glomerular epithelial cells (GECs) and renal tubular cells, as well asinal coiled-coil; GCK, germinal
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lsky).GECs/podocytes in vivo [6]. In addition to its role as a mediator of apo-
ptosis, SLK was shown to co-localize with α-tubulin, especially during
metaphase re-assembly of the mitotic spindle, demonstrating a distinc-
tive role for SLK in cell cycle progression [7]. Apart from its role as a
regulator of cell division and cell death, SLK has been found to cause
actin stress ﬁber dissolution and redistribution to the cell periphery, as
well as promote loss of cellular adhesions [3,5,8]. As a regulator of the
cytoskeleton, the role of SLK may extend from cell cycle regulation to
control of cell motility.
SLK is expressed in many tissues and cell lineages, including the
kidney, as well as muscle and neuronal cells of the developing embryo
[3,4,9]. In the adult kidney, SLK is expressed in tubular and glomerular
epithelial cells [6]. As noted above, SLK expression and activity is in-
creased during development and recovery from ischemia–reperfusion
injury, a pathophysiological event thatmimics certain cellular processes
of kidney development. In cultured glomerular and renal tubular cells,
ischemia–reperfusion activates endogenous SLK leading to activation
of p38 MAPK via apoptosis signal-regulating kinase [10]. This is associ-
ated with an increase in apoptosis.
Structurally, SLK is a large protein consisting of ~1235 amino acids.
SLK contains a N-terminal catalytic/kinase domain (amino acids 1–
338), and is predicted to contain coiled-coil structures in the C-terminal
region (amino acids 826–929 and 942–1038) [3,11,12]. The N-terminal
kinase domain shares high homology with lymphocyte-oriented kinase,
anothermember of the GCK V subfamily [1,2,12,13]. In addition to acting
Table 1
PCR primers.
A) YFP1 and YFP2 (5′–3′)
YFP1-N-Forward: ctagctagcACCATGGTGAGCAAGGGC
YFP2-N-Forward: ctagctagcACCATGAAGAACGGCATCAAG
YFP1-N-Reverse and YFP2-N-Reverse: gatgttaacGGACCCACCACCTCCAGA
YFP1-C-Forward: cggggtaccgGGTGGCGGTGGCTCTG
YFP1-C-Reverse: atagtttagcggccgcTTACTGCTTGTCGGCCATGA
B) SLK coiled-coil mutagenesis (5′–3′)
CC-Forward: GGTCGAAGTAGGCCAGAAATTAAT
CC-Reverse: ATGGGCCCTTATGATCCGGTGGAATGCAA
I878G-Forward: CCAGGAAGGTGAGAATCTCGAAAAAC
I878G-Reverse: TCTAGATTCTCACCTTCCTGGTCA
L986G-Forward: AAGGCAGAGGGAGCTAATATTGAGAGAG
L986G-Reverse: AGCTCCCTCTGCCTTCTGCTG
L986G/I989G-Forward: AGAGGGAGCTAATGGTGAGAGAGAGTGC
L986G/I989G-Reverse:TCACCATTAGCTCCCTCTGCCTTCTG
In part A, lower case letters denote added cDNA sequences encoding restriction
sites.
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regulation of SLK kinase activity. For example, we have previously
shown that mutation of two residues, T183 and S189 to alanine inhibits
SLK phosphorylation, and greatly reduces SLK activity. Despite these
ﬁndings, phosphomimetic T183/S189 SLK mutants did not enhance SLK
kinase activity, suggesting that other post-translational modiﬁcations or
interactions are necessary to promote SLK activity [14]. For example,
homodimerization of the catalytic domain is key to enhancement of
kinase activity. This process may be mediated by the C-terminal coiled-
coil regions of SLK [11,14].
Coiled-coils are comprised of amino acid heptad repeats, containing
hydrophobic residues in the ﬁrst (“a”) and fourth (“d”) positions, and
polar residues in theﬁfth and seventh positions. Thesemotifs are poten-
tial sites of protein–protein interactions, as they can interact with each
other through van der Waals forces [15]. The presence of two coiled-
coil structures in the C-terminal domain of SLK suggests that SLK may
undergo homodimerization or homo-oligomerization, or alternatively
heterodimerize with non-SLK binding partners. Indeed, we have previ-
ously shown that both endogenous and ectopically-expressed SLK are
present in cultured cells as a high molecular mass complex, suggesting
that SLK exists in tight association with other proteins [11]. Actually,
we were not able to detect monomeric SLK. Homodimerization of SLK
is supported by certain experiments; however, to date, little is known
about the potential for SLK to interact with other proteins [16].
The present study addresses interacting partners of SLK that may
co-exist in a high molecular mass complex. By mass spectrometry, we
identiﬁed two interacting partners, the nucleoporin protein, translocated
promoter region (Tpr) [17–19], and the cytoskeletal protein, α-actinin-4
[20,21]. We further conﬁrmed these ﬁndings by protein complementa-
tion assays (PCAs), co-immunoprecipitation, glutathione S-transferase
(GST) pull-down, and immunoﬂuorescence microscopy. We identiﬁed
three amino acid residues required to maintain intact coiled-coil
structures of SLK, as well as the interaction of SLK with Tpr and
α-actinin-4. Finally,we show that Tpr co-localizeswith SLK at the nuclear
envelope and reduces SLK autophosphorylation, a marker of catalytic
activity.
2. Materials and methods
2.1. Plasmid construction and cDNAs
HA-SLK (full length; human), myc-SLK K63R (kinase dead SLK), and
GST-SLK(CT) were described previously [6,10]. Green ﬂuorescent
protein (GFP)-tagged SLKwas kindly provided by Dr. ElenaNadezhdina,
Institute of Protein Research, Moscow, Russia [22]. GFP-Tpr was kindly
provided by Dr. Larry Gerace, Scripps Research Institute, La Jolla, CA
[18]. GFP-α-actinin-4 was described previously [23]. GFP-α-actinin-4
(1–300) and GFP-α-actinin-4 (300–911) were kindly provided by Dr.
Alan Wells, University of Pittsburgh, Pittsburgh, PA [24]. Fragment 1
(amino acids 1–158) or fragment 2 (amino acids 159–239) of Venus
yellow ﬂuorescent protein (YFP) fused via a linker sequence
(GGGGSGGGGS) with GCN4 leucine zipper at the 5′ end in pcDNA3.1,
or fragment 1 of YFP fused via the linker sequence with GCN4 leucine
zipper at the 3′ end in pcDNA3.1 were provided by Dr. Stephen
Michnick, Université de Montréal, Montreal, QC [25–27]. To construct
plasmids for the protein complementation assay (PCA), YFP1 or YFP2
and the linker sequences were ampliﬁed by the polymerase chain
reaction (PCR), using the above plasmids as templates (PCR primer
sequences are presented in Table 1A). YFP1-SLK and YFP2-SLK were
generated by subcloning YFP1 + linker sequence or YFP2 + linker
sequence 5′ of HA-SLK (YFP1-N and YFP2-N primers; Table 1A). YFP1-
Tpr and YFP1-α-actinin-4 were generated by subcloning linker + YFP1
sequence 3′ of Tpr or α-actinin-4, respectively (YFP1-C primers;
Table 1A). All PCR products were veriﬁed by DNA sequencing.
Missense mutations in YFP2-SLK, including I878G, L986G and
L986G/I989G were generated using PCR-based mutagenesis. Twooverlapping PCR products containing each mutation were ampliﬁed
from the C-terminal region of SLK (PacI site at nucleotide 1788 to an
ApaI site just 3′ to the stop codon), using primers containing the muta-
tions. For I878G, the primers included CC-Forward and I878G-Reverse
plus I878G-Forward and CC-Reverse; for L986G, CC-Forward and
L986G-Reverse plus L986G-Forward and CC-Reverse; for L986G/I989G,
CC-Forward and L986G/I989G-Reverse plus L986G/I989G-Forward and
CC-Reverse (Table 1B). The PCR products for each mutation were com-
bined, re-ampliﬁed using CC-Forward and CC-Reverse primers, and
cloned into YFP2-SLK PacI-ApaI sites using the Gibson Assembly Master
Mix Kit (New England Biolabs, Mississauga, ON).
2.2. Cell culture and transfection
Experiments were carried out in COS-1 monkey kidney cells, rat
GECs, and C2C12myoblasts. COS-1 cellswere cultured inDMEMsupple-
mented with 10% fetal bovine serum [10,11]. C2C12 myoblasts were
cultured in the same medium, and were studied 3 days after plating
(prior to differentiation). Rat GECs were characterized previously [28],
and were cultured in K1 medium (DMEM, Ham F-12, with a 5%
NuSerum and hormone mixture) [6]. Cells were seeded into plates
24 h prior to transfection. Cells were transiently transfected using
Lipofectamine 2000 (Invitrogen Life Technologies, Burlington, ON)
according to themanufacturer's instructions. Wemeasured the amount
of overexpression of HA-SLK and GFP-α-actinin-4 by immunoblotting
of cell lysates with anti-SLK [6] or anti-α-actinin-4 antibodies [23],
respectively. After transfection, immunoblotting anddensitometric quan-
tiﬁcation showed that ectopic HA-SLK was expressed 2.7 ± 0.4-fold
above endogenous SLK (6 experiments), and ectopic GFP-α-actinin-4
was 1.5 ± 0.1-fold above endogenous α-actinin-4 (6 experiments).
2.3. Immunoprecipitation, afﬁnity–chromatography and immunoblotting
Cells were rinsed with PBS and lysed with buffer (“lysis buffer”),
containing 1% Triton X-100, 125 mM NaCl, 10 mM Tris (pH 7.5), 1 mM
EGTA, 2 mM Na3VO4, 5 mM Na4P3O7, 25 mM NaF, 20 μM leupeptin ,
10 μM pepstatin, 50 μM bestatin, 15 μM E64, 0.8 μM aprotinin, 1 mM
4-(2-aminoethyl)benzenesulfonylﬂuoride. The lysates were then
centrifuged at 14,000 g for 10 min. Immunoprecipitation of proteins in
the supernatants was carried out with mouse anti-HA antibody IgG
(Santa Cruz Biotechnology, Santa Cruz, CA), rabbit anti-SLK, or nonim-
mune IgG as control, followed by the absorption of complexes using
protein A-coupled agarose beads (Millipore, Billerica, MA). After several
washes, immune complexes were solubilized in Laemmli buffer and
were subjected to SDS-PAGE [6,10]. Alternatively, lysates of cells
that had been transfected with HA-SLK or myc-SLK K63R post-
Fig. 1. Speciﬁcity of SLK pT183 antibody. COS-1 cells were transfected with HA-Fv-SLK
1–373, HA-Fv-SLK 1–373 T183A/S189A (A), or HA-Fv-SLK 1–373 T183A/S189A (B). Cells
were then treated with or without AP20187 (100 nM, 24 h), which induces dimerization
of the SLK catalytic domain. Lysates were immunoblotted with anti-pT183 antibody (and
anti-pS189 for comparison). AP20187 enhanced autophosphorylation of T183 and S189 in
Fv-SLK 1–373. Phosphorylation is absent in the T183A/S189A and T183E mutants (the
faint bands in the pS189 immunoblot are nonspeciﬁc).
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mouse anti-HA or mouse anti-myc antibody coupled to an agarose
matrix (HA or c-Myc tagged protein Mild Puriﬁcation Kits, Medical
and Biological Laboratories, Nagoya, Japan). After several washes,
bound proteinswere eluted from the column usingHA ormyc peptides,
and were subjected to SDS-PAGE.
For immunoblotting, cells were lysed in the buffer described above.
Proteins were loaded onto gels with equal amounts of protein per
lane. Proteins were separated by SDS-PAGE and were then electropho-
retically transferred to a nitrocellulose membrane. Membranes were
blocked with 5% BSA and incubated with primary antibody followed
by horseradish peroxidase-conjugated secondary antibody. Membranes
were developed with ECL (GE Healthcare) [6,10,11,14]. The primary
antibodies included mouse anti-HA, mouse anti-myc, mouse anti-GFP
(Santa Cruz Biotechnology), rabbit anti-SLK, rabbit anti-actinin-4,
mouse anti-Tpr (Abcam), rabbit anti-RRXpS/T (anti-phospho-protein
kinase A substrate, Cell Signaling Technology, Danvers, MA), which
reacts with SLK phospho (p)-S189 [14], and rabbit anti SLK pT183
(discussed below). Density of speciﬁc bands was measured using
National Institutes of Health Image J software. Preliminary studies dem-
onstrated that there was a linear relationship between densitometric
measurements and the amounts of protein loaded onto gels.
2.4. Anti-SLK pT183 antibody
To produce a phosphospeciﬁc antibody directed to SLK pT183,
rabbitswere immunizedwith the peptide, SAKNTRpTIQRRD. Antiserum
was collected, and reactivity against the peptide, as well as the non-
phosphorylated control peptide was tested by ELISA. Antibody was
puriﬁed by passing the antiserum reactive with the phosphopeptide
through a phosphopeptide-afﬁnity column. The eluate was then passed
through a non-phosphorylated peptide-afﬁnity column to remove anti-
body reactingwith non-phosphorylated T183. To validate the speciﬁcity
of the antibody, COS-1 cells were transfected with a cDNA encoding the
SLK catalytic domain, SLK 1-373, fused with a dimerization domain, Fv-
SLK 1-373. Cells were also transfected with Fv-SLK 1-373 T183A/S189A
double mutant [11,14]. Treatment of cells with the dimerizing
compound, AP20187, leads to dimerization and activation of the SLK
kinase domain, which requires the autophosphorylation of T183 and
S189 [14]. By immunoblotting with anti-pT183 antibody (and for com-
parison with the commercially-available anti-pS189 antibody), pT183
and pS189 were enhanced in dimeric Fv-SLK 1–373, and absent in the
1–373 mutant (Fig. 1A). An analogous experiment was carried out
using the Fv-SLK 1–373 T183E mutant [14]. Anti-pT183 antibody
showed no reactivity against the T183 mutant, thereby conﬁrming the
speciﬁcity of the antibody for pT183 (Fig. 1B).
2.5. GST pull-down assay.
GST or GST-SLK(CT) fusion protein, cloned in pGEX vectors
(Amersham Pharmacia Biotech), were induced in Escherichia coli by
the addition of isopropyl-1-thio-β-D-galactopyranoside, according to
the manufacturer's instructions [6]. After lysis of bacteria by sonication
in buffer containing protease and phosphatase inhibitors, GST or
GST-SLK(CT) were adsorbed using glutathione–agarose beads (Sigma-
Aldrich), according to the Amersham instructions. Equal aliquots
of GST-glutathione–agarose and GST-SLK(CT)-glutathione–agarose
(~25 μl) were treated with Laemmli buffer and loaded onto a gel
together with BSA standards. After SDS-PAGE, the gel was stained
with Coomassie Blue. The protein concentration was estimated by
comparing the intensity of the GST and GST-SLK(CT) bands to BSA
standards. For pull-down assays, cells were treated with lysis buffer.
Cell lysates (500 μg protein in 250 μl lysis buffer) were precleared by
incubation with 25 μl agarose beads for 30min at 4 °C. Then, cell lysates
were incubated with GST- or GST-SLK(CT)-glutathione–agarose beads
overnight at 4 °C [11]. After washing four times with lysis buffer,proteins were eluted in Laemmli buffer, and subjected to SDS-PAGE.
Immunoblotting was carried out as described above.
2.6. Puriﬁcation of SLK and mass spectroscopy analysis.
COS-1 cells transfectedwithHA-SLK, or untransfected cells (control)
were lysed and centrifuged, and were then separately applied to an
anti-HA antibody afﬁnity column, as described above. After washes,
bound proteins were eluted from the column using HA peptide, and
were subjected to SDS-PAGE. Gels were stained with Coomassie Blue
and samples were analyzed in the McGill Mass Spectrometry facility,
according to standard methods. Brieﬂy, selected regions of gels were
cut, destained, and subjected to reduction and in-gel digestion with
trypsin. Samples were analyzed in a Brooker HCT-Ultra ion trap mass
spectrometer (Agilent Technologies).
2.7. Immunoﬂuorescence microscopy
Cells were plated on glass cover slips and were transfected as
described above. Forty-eight hours following transfection, cells were
ﬁxed in 4% paraformaldehyde diluted in PBS and then permeabilized
using 0.1% Triton X-100 diluted in PBS. Cover slips were blocked in 3%
BSA and incubated with primary anti-HA or anti-Tpr antibody IgGs di-
luted in 3% BSA, followed by rhodamine-conjugated secondary antibody
diluted in 3% BSA. After washing, cell nuclei were stained with Hoechst
H33342 dye (Molecular Probes). Coverslips were mounted onto glass
slides using medium containing an antifade component. Images were
acquired at intensity below saturation using a Zeiss AxioObserver
ﬂuorescence microscope with visual output connected to an AxioCam
digital camera. The images were collected from series of images derived
from different focal planes (Z-stack) [29].
2.8. Quantiﬁcation of apoptotic cells by Hoechst staining
Following transfection, COS-1 cells were stained using Hoechst
H33342 dye (1 μg/ml) for 10 min at 37 °C without ﬁxation. After
washing with PBS, cells were stained with propidium iodide (5 μg/ml).
Images at high magniﬁcation were acquired using the ﬂuorescence
Fig. 2. Identiﬁcation of potential SLK-interacting proteins. Lysates of COS-1 cells
transfected with HA-SLK, or empty vector in control were subjected to afﬁnity–chroma-
tography using agarose-coupled anti-HA antibody. After elution with HA peptide, the elu-
ates were subjected to SDS-PAGE (duplicate samples). The gel was stained with
Coomassie Blue. HA-SLK is observed at ~200 kDa (arrow). Three regions of the gel cover-
ing ~95–300 kDa (denoted by the brackets on the right of the gel) were excised and ana-
lyzed separately by mass spectroscopy.
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counted manually. Cell nuclei, which showed chromosomal condensa-
tion and/or fragmentation, but which had an intact plasma membrane
impermeable to propidium iodide, were counted as apoptotic.
Propidium iodide-positive cells were classiﬁed as necrotic, and other
Hoechst H33342-stained cells without propidium iodide staining were
designated as normal [6,10,11,14].2.9. Dual luciferase reporter assay
COS-1 cells were plated and co-transfected after 24 h with the cDNA
of interest, pRL-TK (renilla luciferase), and activator protein-1 (AP-1)
ﬁreﬂy luciferase reporter [14]. pRL-TK serves as an internal control
that quantiﬁes transfection efﬁciency, whereas ﬁreﬂy luciferase serves
as the principal reporter. Cell lysates were assayed using the Dual-
Luciferase Reporter Assay System (Promega, Madison, WI). Luciferase
activity was measured in a Berthold Lumat LB 9507 luminometer.2.10. Statistics
Results are presented asmean± SEM. One-way analysis of variance
was used to determine signiﬁcant differences among groups. Where
signiﬁcant differences were found, individual comparisons were made
between groups using the t statistic, and adjusting the critical value ac-
cording to the Bonferroni method. The t test was used to assess signiﬁ-
cant differences between two groups.Table 2
Mass spectroscopy results.
Experiment 1
Peptide match TSC
T C T
HA-SLK 15 – 573
α-Actinin-4 42 – 1585
Tpr 67 – 3008
LRP-1 45 – 1574
AHNAK 6 – 168
Lysates of COS-1 cells, transfected with full-length HA-SLK (T), or empty vector in control (C), w
elutionwith HApeptide, the eluateswere subjected to SDS-PAGE. Regions of the gel covering ~9
matches and total spectral counts (TSC) of 2 experiments are presented. Proteins with at least
(α2-macroglobulin receptor), AHNAK, neuroblast differentiation-associated protein AHNAK is3. Results
3.1. Identiﬁcation of two novel SLK-interacting partners: α-actinin-4 and
translocated promoter region (Tpr)
We have previously shown that both endogenous and exogenously-
expressed SLK are present as high molecular mass complexes, but are
undetectable in monomeric form in COS-1 cells. These results suggest
that SLK exists in vivo mainly as a dimer or oligomer, or SLK is in tight
association with other proteins [11]. In order to identify potential SLK-
interacting partners that may be present in this high molecular-mass
complex, lysates of COS-1 cells transfected with full-length HA-SLK (or
empty vector in control) were subjected to afﬁnity-chromatography
using agarose-coupled anti-HA antibody. After elution with HA peptide,
the eluates were subjected to SDS-PAGE. Proteins were visualized with
Coomassie Blue staining (Fig. 2), and three regions of the gel covering
~95–300 kDa were excised and analyzed separately by mass spectros-
copy for peptides speciﬁcally co-purifying with HA-SLK (judged by
total spectral counts and number of unique peptides; Table 2). Peptides
of SLK were detected by mass spectroscopy only in the lysates of COS-1
cells that had been transfected with HA-SLK, but not in vector-
transfected cells, conﬁrming the speciﬁcity of the puriﬁcation
technique. Peptides of two other proteins, α-actinin-4 (a 105 kDa
cytoskeletal protein), and Tpr (a 267 kDa nucleoporin), were enriched
in afﬁnity-puriﬁed lysates of HA-SLK-transfected COS-1 cells (Table 2),
and were further investigated as potential binding partners of SLK.3.2. SLK homodimerizes and heterodimerizes with α-actinin-4 and Tpr
In the ﬁrst set of experiments, we examined whether SLK
homodimerizes and if SLK can associate with α-actinin-4 and Tpr in
cells in vivo. We studied these interactions by employing a PCA
[25–27]. In the PCA, protein–protein interactions are measured by
fusing each of the proteins of interest to two fragments of a reporter
protein that has been expressed as two separate fragments using pro-
tein engineering strategies. The two reporter protein fragments are
brought into proximity after association of the two interacting proteins,
allowing the reporter protein fragments to fold together into the three
dimensional structure of the reporter. We generated SLK, α-actinin-4
and Tpr cDNAs fused to cDNAs encoding fragments of yellow ﬂuores-
cent protein, referred to as either YFP1 or YFP2 [27]. Full-length SLK
was tagged separately with either YFP1 or YFP2, while α-actinin-4
and Tpr were both fused to YFP1. After transfection, all proteins were
expressed in COS-1 cells (Figs. 3A and 4A).
Previously, we showed that GST-SLK(CT), a GST fusion protein
containing the 350 C-terminal amino acids of SLK, including the
coiled–coiled regions [6,10,11], can bind to full-length SLK and to aExperiment 2
Peptide match TSC
C T C T C
– 5 – 172 –
– 23 1 1101 56
– – – – –
– – – – –
– – – – –
ere subjected to afﬁnity–chromatography using agarose-coupled anti-HA antibody. After
5–300 kDawere excised and analyzed separately bymass spectroscopy. Results of peptide
5 peptide matches are presented. LRP1, low-density lipoprotein receptor-related protein 1
oform 1.
Fig. 3.Homodimerization of SLK demonstrated by the protein fragment complementation assay. A) Expression of SLK fusion proteins in COS-1 cells by transfection. B–E) COS-1 cells were
transfectedwith YFP1-SLK and YFP2-SLK (B), YFP1-SLK and YFP2-linker (C), YFP2-SLK alone (D), or GFP-SLK (E). A) Immunoblots with anti-HA or anti-SLK antibodies show expression of
YFP1-SLK and YFP2-SLK (left panel), and GFP-SLK (right panel). Untransfected cells (Un) andHA-SLK transfections are presented for comparison. The YFP1-SLK and YFP2-SLK also express
theHA tag. Thedifferences inmolecularmass amongHA-, YFP1- and YFP2-SLK are small, and therefore themigration of the three forms of SLK on the gel is comparable. B) YFPﬂuorescence
is evident only in the YFP1-SLK + YFP2-SLK transfection. The upper set of panels shows cells in interphase; the lower set shows a mitotic cell. The pattern of YFP1-SLK + YFP2-SLK ﬂuo-
rescence in interphase cells is similar to the ﬂuorescence of GFP-SLK (E). Nuclei are stained with Hoechst H33342 (3–8 experiments). Bar = 20 μm.
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can undergo homodimerization [10]. To demonstrate that SLK
homodimerizes in cells, we co-expressed YFP1-SLK with YFP2-SLK,
using the same transfection conditions that demonstrated expression
of the two proteins by immunoblotting (Fig. 3A). Upon direct interac-
tion of the two tagged SLK proteins, both fragments of YFP will come
together, and form a reconstituted YFP that emits a ﬂuorescent signal.
After co-expression, we detected prominent intracellular ﬂuorescence
of YFP (Fig. 3B), most likely indicating a direct interaction between
the differentially-tagged SLK monomers. By visual counting, we esti-
mated that 21.9 ± 2.4% of cells demonstrated YFP ﬂuorescence (479
cells counted in total). The majority of cells displaying reconstituted
YFP ﬂuorescence were in interphase; however, ﬂuorescence was also
detected in occasional mitotic cells (Fig. 3B, inset). In control experi-
ments, where YFP1-SLK was expressed with YFP2-linker or YFP2-SLKwas expressed alone, there were no ﬂuorescence signals detected
(Fig. 3C and D). Expression of YFP1-SLK alone also did not yield a
detectable ﬂuorescence signal (result not shown). The ﬂuorescence of
co-expressed YFP1-SLK and YFP2-SLK was predominantly cytoplasmic,
but there was also perinuclear localization (Fig. 3B; upper panels). This
ﬂuorescence pattern was identical to the one observed after expressing
GFP-SLK (Fig. 3E).
Next, YFP2-SLK was co-expressed with YFP1-α-actinin-4 (Fig. 4A
and B) or YFP1-Tpr (Fig. 4A and D) in COS-1 cells. As controls, both
YFP1-α-actinin-4 and YFP1-Tpr were expressed with YFP2-linker
(Fig. 4C and E, respectively). When each of the two fusion proteins
was co-expressed with YFP2-SLK, ﬂuorescence signals were detected,
suggesting assembly of heterodimers composed of SLK and α-actinin-
4 (Fig. 4B) or SLK and Tpr (Fig. 4D). However, when YFP1-α-actinin-4
or YFP1-Tpr was expressed with YFP2-linker, we did not detect any
Fig. 4. Interaction of SLKwith Tpr andα-actinin-4 demonstrated by the protein fragment complementation assay. A) Expression of SLK,α-actinin-4 and Tpr fusion proteins in COS-1 cells
by transfection. In panel A (and in Fig. 5A, below), thewhite space denotes reassembly of noncontiguous gel lanes; therewere no adjustmentsmade to the digital images among the lanes
that would alter the information in the panels. B–E) COS-1 cells were transfectedwith YFP1-α-actinin-4 and YFP2-SLK (B), YFP1-α-actinin-4 and YFP2-linker (C), YFP1-Tpr and YFP2-SLK
(D), or YFP1-Tpr and YFP2-linker (E). Anti-GFP antibody immunoblots (A) show expression of YFP2-SLK, YFP1-α-actinin-4 and YFP1-Tpr. GFP-α-actinin-4 and GFP1-Tpr are shown for
comparison (Un, untransfected;NS, non-speciﬁc band). YFPﬂuorescence is evident in theYFP1-α-actinin-4+YFP2-SLK (B) andYFP1-Tpr+YFP2-SLK transfections (D). Nuclei are stained
with Hoechst H33342 (3–7 experiments). Bar = 20 μm.
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expressed by immunoblotting (Fig. 4A). As additional controls, expres-
sion of YFP1-α-actinin-4 or YFP1-Tpr alone did not yield detectable
ﬂuorescence (results not shown). With the 10 amino acid length of
the linker we employed in our YFP fusion proteins, the positive PCA
ﬂuorescence signal would require a protein–protein interaction at a dis-
tance not exceeding ~40 Å [26]. Theoretically, a scaffolding protein
might be involved, but it would need to be a protein of only ~180–200
amino acids, or scaffolding sites would have to be within 180–200
amino acids in a larger protein. Thus, these results together support
the view that interactions between SLK and α-actinin-4, as well as SLK
and Tpr are probably direct.
The YFP ﬂuorescence reconstituted by SLK-Tpr or by SLK-α-actinin-
4 heterodimers appeared weaker and less frequent than that observedfor SLK homodimers. Thus, in contrast to SLK–SLK homodimerization
(21.9 ± 2.4% of cells), we estimated that α-actinin-4-SLK heterodimers
were present in only 7.6 ± 0.8% of cells (942 cells counted in total, p b
0.0001 vs SLK homodimers), while Tpr-SLK heterodimers were present
in only 6.4 ± 1.0% of cells (374 cells counted in total, p b 0.0001 vs SLK
homodimers). Moreover, to visualize SLK–SLK homodimerization, we
co-transfected cells with 0.25 μg of YFP1-SLK and YFP2-SLK plasmid
DNAs per culture plate, but to visualize heterodimers of YFP2-SLK
with YFP1-α-actinin-4 or YFP1-Tpr, co-transfection of 0.5–1.0 μg of
the plasmid DNAs was required. It should be noted that quantitative
comparisons of homodimerization versus heterodimerization are
estimates, because the ﬂuorescence signal in the PCA is dependent on
the expression levels of YFP-tagged proteins, aswell as expression of en-
dogenous proteins, which can compete with the ectopic proteins [25].
Fig. 5. SLK interacts with Tpr and α-actinin-4. A) COS-1 cells were co-transfected with
GFP-Tpr (+), and myc-SLK K63R (kinase dead SLK; +) or vector (control;−). Lysates
were subjected to anti-myc afﬁnity–chromatography. Samples were washed and proteins
were elutedwithmycpeptide. Lysates and eluateswere immunoblottedwith anti-GFP an-
tibody. GFP-Tpr was present only in the eluate of myc-SLK K63R-transfected cells. Immu-
noblotting of the eluate of myc-SLK K63R-transfected cell with anti-myc antibody
demonstrates myc-SLK in the transfected cells. B) COS-1 and C2C12 cell lysates were
immunoblotted with anti-SLK antibody. Expression of endogenous SLK in C2C12 myo-
blasts (lane 3) is greater, compared with COS-1 cells (lane 2), and slightly greater than
COS-1 cells transfectedwith HA-SLK (lane 1). C) C2C12 cells were treatedwith lysis buffer
(see the Materials and methods section) and the lysates were immunoprecipitated (IP)
with anti-SLK antibody (+), or non-immune IgG in control (−). After absorption with
protein A, the immune complexeswere subjected to SDS-PAGE, andwere immunoblotted
(IB) with antibodies to Tpr, α-actinin-4, or SLK. Endogenous Tpr and α-actinin-4 co-
immunoprecipitated with SLK (+ lane). There are no speciﬁc bands in the control lane
(−).
Fig. 6. The C-terminal domain of SLK interacts with Tpr and α-actinin-4. A) Expression of
GST and GST-SLK(CT) fusion protein is presented. Aliquots of GST-glutathione–agarose
and GST-SLK(CT)-glutathione–agarose were treated with Laemmli buffer and loaded
onto a gel. The gel was stained with Coomassie Blue. B–E) Cells were transfected with
GFP-α-actinin-4 (full length; B), GFP-α-actinin-4 1–300 (C), GFP-α-actinin-4 300–911
(D), or GFP-Tpr (E). Lysates (L) were incubatedwith GST-SLK(CT), or GST alone (control),
bound to glutathione–agarose. Samples were washed 4 times, eluted from glutathione–
agarose (E), and immunoblotted with anti-GFP antibody. After comparable amounts of
input (lanes “L”), there is speciﬁc binding of GFP-α-actinin-4 (B), GFP-α-actinin-4 1-300
(C), or GFP-Tpr (E) to GST-SLK(CT) (lower panels), but not to GST (upper panels). Howev-
er, binding of GFP-α-actinin-4 300–911 to GST-SLK(CT), is absent (D). Immunoblots are
representative of at least 3 experiments. F) Cell lysates were incubated with GST-
SLK(CT), or GST bound to glutathione–agarose, or glutathione–agarose alone. Eluates
were immunoblotted with anti-α-actinin-4 antibody. There is speciﬁc binding of endoge-
nous α-actinin-4 only to GST-SLK(CT).
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To further address the association of SLK with Tpr, COS-1 cells were
co-transfected with GFP-Tpr and HA-SLK, or vector (control). Cell
lysates were applied to an anti-HA afﬁnity-column, samples were
washed and eluted with HA peptide, and the washes and eluates were
immunoblotted with anti-GFP antibody. GFP-Tpr was present in the
eluate of HA-SLK-transfected cells but not in vector transfection (results
not shown). By analogy, lysates of cells transfected with GFP-Tpr and
myc-SLK K63R (kinase dead SLK) were applied to an anti-myc afﬁnity-
column. Immunoblotting with anti-GFP antibody showed that GFP-Tpr
was present in the eluate of myc-SLK-transfected cells, but not in vector
transfection (Fig. 5A). Similar experiments were repeated with lysates
of COS-1 cells that had been co-transfected with GFP-α-actinin-4 and
myc-SLK K63R. However, GFP-α-actinin-4 bound avidly and non-
speciﬁcally to the anti-myc afﬁnity column, and this technique was
unable to detect a speciﬁc interaction of SLK with α-actinin-4 (results
not shown).
To examine the interaction of endogenous SLKwith endogenous Tpr
and α-actinin-4, we switched to C2C12 myoblasts. This cell line
expresses endogenous SLK at a higher level, compared with COS-1
cells (Fig. 5B). Moreover, expression of SLK in C2C12 myoblasts is
slightly greater than in COS-1 cells transfected with HA-SLK (Fig. 5B).
Immunoprecipitation of C2C12 lysates with anti-SLK antibody showed
co-immunoprecipitation of endogenous Tpr and α-actinin-4 (Fig. 5C),
conﬁrming the results obtained with ectopic proteins in COS-1 cells.
Next, we examined the interaction of SLK with α-actinin-4 and Tpr
by a pull-down assay, using GST-SLK(CT), or GST in controls (Fig. 6A).GFP-α-actinin-4 was expressed in COS-1 cells. With comparable
amounts of COS-1 cell lysate input, GFP-α-actinin-4 bound speciﬁcally
to GST-SLK(CT), but not to GST alone (Fig. 6B; compare lanes 6 of the
upper and lower panels). Similarly, a truncated form of GFP-α-actinin-
4, containing amino acids 1 to 300 also bound to GST-SLK(CT)
(Fig. 6C; compare lanes 6 of the upper and lower panels). In contrast,
the C-terminal region of α-actinin-4 (amino acids 300–911) did not in-
teract with GST-SLK(CT) (Fig. 6D). These results indicate that the ﬁrst
300 amino acids of α-actinin-4, which contain the two F-actin binding
domains and several spectrin-like coiled-coil repeats [21], are involved
in mediating the interaction with the C-terminal region of SLK. Similar
Fig. 7. SLK co-localizeswithα-actinin-4 and Tpr in COS-1 cells (A, C and E) andGECs (B and D). Cells were transfectedwith HA-SLK (A–D), andwith GFP-α-actinin-4 (A and B), or GFP-Tpr
(C and D). After ﬁxation, cells were stained with anti-HA antibody (red), and in some cases, nuclei were stained with Hoechst H33342. GFP-α-actinin-4 (green ﬂuorescence) localizes in
the cytoplasm, partly in a cytoskeletal pattern, in the perinuclear regions, and along the periphery of cells. Co-localization of HA-SLK is evident in the cytoplasm and perinuclear region
(orange-yellow ﬂuorescence), but there are also areas where the two proteins do not colocalize (A and B). GFP-Tpr is in the nuclear envelope, and there is distinct HA-SLK co-localization
in the nuclear envelope (C and D; arrows). E) Cells were transfected with GFP-SLK and were stained with anti-Tpr antibody. By analogy to GFP-Tpr, endogenous Tpr is in the nuclear en-
velope, and colocalization with GFP-SLK is evident (arrows). Bars = 10 μm.
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(Fig. 6E; compare lanes 6 of the upper and lower panels), indicating
that Tpr also interacts with the C-terminal region of SLK. It is important
to note that in addition to ectopic GFP-α-actinin-4, endogenous
α-actinin-4 bound speciﬁcally to GST-SLK(CT), but not to GST alone,
nor to glutathione–agarose (Fig. 6F).
3.4. SLK co-localizes with α-actinin-4 and Tpr
A distinct advantage of the PCA is that it shows the subcellular
localization of the interaction. Thus, the SLK-α-actinin-4 heterodimers
were presentmainly in the cytoplasmof COS-1 cells, with enhancement
around nuclei (Fig. 4B). SLK-Tpr heterodimerswere primarily at the nu-
clear envelope; that is, the ﬂuorescent signal appeared predominantly
at the edge of the Hoechst H33342-stained nuclei (Fig. 4D).
To further investigate the co-localization of SLK with α-actinin-4
and Tpr, we co-expressed HA-SLK and GFP-α-actinin-4 or GFP-Tpr in
COS-1 cells and GECs (Fig. 7). The cells were stained with anti-HA and
rhodamine-conjugated secondary antibodies. α-Actinin-4 was present
in the cytoplasm and perinuclear region of COS-1 cells, and partial
co-localization of α-actinin-4 with SLK was evident (Fig. 7A and B,
orange-yellow ﬂuorescence). Localization of α-actinin-4 extended to
and included the cell periphery, whereas SLK ﬂuorescence tended to
be more central, and was fainter at the peripheral location (Fig. 7A
and B). In GECs, the pattern of GFP-α-actinin-4 was more punctate,
comparedwith COS-1 cells. In keepingwith the results of several previ-
ous studies [17–19,30,31] the localization of GFP-Tpr in COS-1 cells
(Fig. 7C) and GECs (Fig. 7D), as well as endogenous Tpr in COS-1 cells
(Fig. 7E) was in the nuclear envelope, i.e. the ﬂuorescent signal
circumscribing the Hoechst H33342-stained nuclei (Fig. 7D). HA-SLK
was primarily localized in the cytoplasm; however, closer examination
revealed a distinct overlapping presence of SLK with GFP-Tpr (Fig. 7C
and D), and importantly, with endogenous Tpr (Fig. 7E) in the nuclear
envelope.
3.5. Mutations in the coiled-coil domains of SLK reduce homodimerization
and interactions of SLK with Tpr and α-actinin-4
Based on the above experiments, it is reasonable to propose that the
C-terminal domain of SLK is sufﬁcient to mediate homodimerization, as
well as interactionswithα-actinin-4 and Tpr. Analysis of the SLK amino
acid sequence shows that the C-terminal domain is predicted to contain
two coiled-coil regions, which we have designated as the N-terminal
coiled-coil (NTC; amino acids 826–929) and the C-terminal coiled-coil
(CTC; amino acids 942–1038) [11]. The SLK coiled-coils display typical
heptad repeats with hydrophobic residues in the “a” and “d” positions
[32]. To further investigate the role of these coiled-coil domains in
mediating protein–protein interactions, we introduced point mutations
in the NTC and CTC, with the purpose of disrupting the coiled-coil
structures. The I878G mutation, as well as the L986G and I989G
mutations (all in the “a” or “d” positions) are predicted to disrupt the
NTC and CTC, respectively [32]. Based on these predictions, we generat-
ed two single mutations in SLK, including YFP2-SLK(I878G) and
YFP2-SLK(L986G), as well as the double mutation, YFP2-SLK(L986G/
I989G).
First, we used the PCA to assess the impact of the NTC and CTC
mutations on the homodimerization of SLK. Compared with the recon-
stitution of YFP ﬂuorescence by expression of wild type homodimers
(i.e. YFP1-SLK plus YFP2-SLK), there was a ~70% reduction in YFP
ﬂuorescence when YFP1-SLK was co-expressed with YFP2-SLK(I878G)
(Fig. 8A and B). Co-expression of YFP1-SLK with YFP2-SLK(L986G) or
YFP2-SLK(L986G/I989G) resulted in a 40–50% reduction in ﬂuorescence
(Fig. 8A and B). Reduction in ﬂuorescence occurred despite robust
expression of the three mutants, shown by immunoblotting (Fig. 8C).
These experiments indicate that the C-terminal coiled-coiled regions
of SLK are structurally important in mediating homodimerization,with the NTC probably more signiﬁcant, compared with the CTC;
however, single or even double point mutations were not sufﬁcient
to disrupt dimerization entirely. In control experiments, where the
three YFP2-SLK mutants were expressed alone, none of the mutant
proteins emitted a detectable ﬂuorescence signal (results not
shown).
To assess the role of the C-terminal coiled-coiled regions of SLK on
heterodimerization (by the PCA), we co-expressed YFP1-Tpr or YFP1-
α-actinin-4 with each of the three YFP2-tagged SLK coiled-coil mutants
in COS-1 cells. In all cases, therewas no complementation of YFP detect-
ed, indicating that the SLK coiled-coil mutations abolished the interac-
tions of SLK with Tpr and α-actinin-4 (Fig. 8D). Thus, the impact of
the three SLK coiled-coil mutations on heterodimerization appeared to
be more substantial, compared with homodimerization.3.6. Tpr reduces SLK autophosphorylation
SLK catalytic activity is dependent on autophosphorylation of two
conserved serine and threonine residues, S189 and T183, in the catalyt-
ic/kinase domain [14]. To determine if the interaction of SLK with
α-actinin-4 and Tpr can modulate the catalytic activity of SLK, we
examined changes in the autophosphorylation of S189 and T183 in
SLK, using phosphospeciﬁc antibodies [14]. HA-tagged SLK was
expressed in COS-1 cells either alone, or with GFP-α-actinin-4 or
GFP-Tpr. SLK was immunoprecipitated from cell lysates with anti-HA
antibody, and phosphosphorylation was determined by immuno-
blotting. Co-expression of SLK with Tpr reduced S189 and T183
autophosphorylation signiﬁcantly (Fig. 9A and B), implying that
overexpression of Tpr was associated with a reduction in SLK catalyt-
ic activity. It should be noted that autophosphorylation of SLK was
reduced by only ~30% in these experiments; however, given its
subcellular localization, Tpr most likely interacted with only a fraction
of total cellular SLK. In contrast to Tpr, co-expression of SLK with
GFP-α-actinin-4 did not alter S189 and T183 autophosphorylation
signiﬁcantly (Fig. 10A and B).3.7. Tpr decreases the signaling of SLK
We and others have shown that a functional consequence of SLK
activation is the induction of apoptosis [6]. Since Tpr reduced SLK
autophosphorylation, we hypothesized that Tpr may also reduce SLK-
mediated induction of apoptosis. To investigate this possibility, we
co-expressed SLK in the presence or absence of GFP-Tpr. After 48 h,
quantiﬁcation of apoptotic cells was determined by counting cells that
showed chromosomal condensation and/or nuclear fragmentation
(Hoechst stain), and absence of propidium iodide. In keeping with
earlier results, expression of SLK increased the number of apoptotic
cells, compared with vector (Fig. 9C, inset). In the presence of GFP-
Tpr, SLK-induced apoptosis was markedly reduced (Fig. 9C). Basal apo-
ptosis in Tpr-expressing cells was similar to that in empty-vector
transfected cells (Fig. 9C and inset). Therefore, the reduction in SLK
autophosphorylation in the presence of Tpr is functionally important,
as it is associated with reduced proapoptotic action of SLK.
To further address the effect of Tpr on the function of SLK, we exam-
ined SLK-induced activation of AP-1. AP-1 is a transcription factor that
lies downstream of pathways, including c-Jun N-terminal kinase and
p38, and controls a number of cellular processes, such as differentiation,
proliferation, and apoptosis. Previously, we showed that SLK stimulates
AP-1 activity (monitored with an AP-1-luciferase reporter), and that
this effect was dependent on T183 and S189 phosphorylation [14]. In
keepingwith these earlier results, SLK stimulated AP-1 reporter activity;
however, the stimulatory activity of SLK was blocked in the presence of
Tpr (Fig. 9D). Expression of Tpr alone did not affect AP-1 reporter
activity.
Fig. 8.Mutations in the coiled-coil domains of SLK reduce homodimerization of SLK and disrupt heterodimerization, demonstrated by the protein fragment complementation assay. See
legend to Fig. 4. A) COS-1 cells co-expressing YFP1-SLK (wild type) with YFP2-SLK(I878G), YFP2-SLK(L986G), or YFP2-SLK(L986G/I989G). Upper panel shows low magniﬁcation photo-
micrographs of YFP1-SLK + YFP2-SLK (wild type) and YFP1-SLK + YFP2-SLK(I878G). Bar = 120 μm. Lower panel shows high magniﬁcation photomicrographs of YFP-SLK co-expressed
withmutants. Bar=20 μm.Ahighmagniﬁcation photomicrograph of YFP1-SLK+YFP2-SLK (wild type) is shown in Fig. 4A. B)Quantiﬁcation of YFPﬂuorescence, expressed as the fraction
of total cells that were YFP-positive. Compared with wild type SLK, all mutations reduced the YFP complementation signal, with the I878G mutation showing the greatest effect. *P b
0.0005, **P b 0.003, +P b 0.001 vswild type (3 experiments). C) Anti-SLK antibody immunoblot demonstrates comparable expression of YFP1-SLK (wild type) and the three YFP2-tagged
mutants. D) COS-1 cells co-expressing YFP1-α-actinin-4 (upper panels), or YFP1-Tpr (lower panels) with the three SLK mutants. Compared with wild type YFP2-SLK complementation
(Fig. 4B and D), the SLK mutants show a complete absence of YFP ﬂuorescence. Bar = 20 μm.
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injury
In a previous study, we showed enhanced expression and activity of
SLK in renal ischemia–reperfusion injury [6]. Although ischemia–reperfusion is a complex pathophysiological model, we examined if
Tpr can modulate SLK signaling during ischemia–reperfusion (chemical
anoxia/recoverymodel) [6]. COS-1 cells expressing SLK and/or Tprwere
subjected to glucose depletion and chemical anoxia, followed by
recovery in glucose-replete medium (Supplementary Table 1). In
Fig. 9. Tpr reduces SLK autophosphorylation and signaling. COS-1 cellswere transfectedwithHA-SLK, GFP-Tpr or vector. A and B) Lysateswere immunoprecipitatedwith anti-HA antibody
(non-immune IgG in controls), and were immunoblotted with anti-pT183, anti-pS189, or anti-HA antibodies (in duplicate). Cell lysates were immunoblotted with anti-HA or anti-GFP
antibodies (in duplicate) to demonstrate expression of HA-SLK andGFP-Tpr. Phosphorylation of S189 and T183 in SLKwas reduced in the presence of Tpr. A) representative immunoblots.
B) densitometric quantiﬁcation; *P b 0.025 GFP-Tpr vs vector, 3 experiments performed in duplicate. C) Apoptotic signaling. After 48 h, transfected COS-1 cells were stained with Hoechst
H33342 to quantify apoptotic nuclei. GFP-Tpr signiﬁcantly reduced the amount of apoptosis; *P= 0.001 HA-SLK vs GFP-Tpr, P b 0.0002, vs HA-SLK+GFP-Tpr (4 experiments). GFP-Tpr is
not signiﬁcantly different from HA-SLK+GFP-Tpr. The inset shows the apoptotic effect of SLK, compared with vector; **P b 0.0001 HA-SLK vs Vector (3 experiments performed in dupli-
cate). Values are normalized to SLK transfection,where themean number of apoptotic cells was ~10% of total cells. D) AP-1 luciferase reporter assay. COS-1 cells were transfected as above,
together with AP-1 luciferase and renilla luciferase reporters. Luciferase activity was measured after 48 h (*P b 0.01 HA-SLK vs vector, P b 0.04 vs HA-SLK + GFP-Tpr, 4 experiments per-
formed in triplicate).
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effect of SLK on the AP1-reporter tended to be enhanced, and in the
presence of Tpr, the stimulatory effect of SLK was enhanced further
(Supplementary Table 1). This result supports the functional impor-
tance of the SLK-Tpr interaction, but themechanism for why SLK signal-
ing in anoxia/recovery was not reduced by Tpr will require additional
study. Oxidative stress, which is seen during recovery/reperfusion,
was reported to be associated with mislocalization, post-translational
modiﬁcation or disruption of nucleoporins [33]; thus, ischemia–reper-
fusion may have altered Tpr, and/or changed the interaction of Tpr
with SLK.
4. Discussion
We have previously shown by gel-ﬁltration chromatography that
both ectopically and endogenously-expressed forms of SLK were
present in cells as high molecular mass complexes, greater in size than
would be predicted from the monomeric molecular mass of SLK [11].In this study,we show that coiled-coil domains [15] in the C-terminal do-
main of SLK mediate its homodimerization, and its heterodimerization
with Tpr and α-actinin-4, two novel SLK binding partners (Fig. 11).
Subcellular localization and functional assays suggest a role for SLK
heterodimers in cytokinesis and apoptosis.
Tpr is one of the largest members of the nucleoporin family, and was
shown to assemble into a coiled-coil homodimer through its N-terminus
at the nucleoplasmic side of the nuclear pore complex, forming a “basket-
like” structure [17,18,30]. The SLK-Tpr interaction was validated using
four independent methods, including PCA, co-immunoprecipitation,
GST pull-down, and immunoﬂuorescence microscopy (Figs. 4–7). Using
PCA and immunoﬂuorescence microscopy, we visualized the interaction
of SLK with both ectopic and endogenous Tpr predominantly at the
nuclear envelope.
Recent studies have demonstrated that Tpr functions as a scaffolding
element in a channel at the nuclear membrane, allowing for the trans-
port of both spliced and unspliced mRNAs, as well as nuclear proteins
across the nuclear membrane [18,34,35]. Additionally, it has been
Fig. 10. SLK autophosphorylation of S189 and T183 is not affected byα-actinin-4 (protocol
similar to Fig. 9A and B). A, Representative immunoblots. B, Densitometric quantiﬁcation;
3 experiments performed in duplicate.
Fig. 11. Summary of protein-protein interactions. Homodimerization of SLK (A) or
heterodimerization of SLK with Tpr (B) or α-actinin-4 (C) leads to YFP complementation
and a ﬂuorescence signal. Missense mutations in either coiled-coil (CC) region of SLK (in-
dicated by the arrowheads) reduce or prevent homo- (D) and heterodimerization (E and
F).We cannot distinguishwhether Tpr orα-actinin-4monomers interactwith SLKmono-
mers (as illustrated), or if the interactions are those of heterodimers or homodimers.
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Tpr to the nuclear pore complex, and facilitate transport into the nucle-
us [18,36]. Although previous studies have not demonstrated a role for
SLK in nuclear transport, one possibility is that SLK could facilitate the
anchoring of Tpr to the nuclear pore complex, perhaps through its phos-
phorylation. Alternatively, SLK could regulate the removal of Tpr from
the nuclear envelope during mitosis. In mitotic cells, Tpr has been
shown to localize at the spindle pole, and play a functional role during
cell division and mitotic spindle signaling checkpoints [18,22,31,35,
37]. Furthermore, Tpr was found to be transported by the molecular
motor dynein complex ensuring efﬁcient recruitment of check point
proteins, mitotic arrest deﬁcient 2-like protein-1 and protein-2,
supporting appropriate anaphase formation and preventing chromo-
somal lagging [31,37]. In turn, SLK was shown to be a component of
the mitotic spindle, and its kinase activity was required for cell cycle
progression through the G2/M phase [7,38]. A recent study has shown
that SLK-dependent phosphorylation and activation of ezrin, radixin
and moesin is required for correct orientation of the mitotic spindle in
metaphase cells [39]. Paradoxically, overexpression of SLK has been
shown to induce apoptosis [3]. These two opposing roles of SLK have
been reconciled by the hypothesis that overexpression of SLK mayforce a cell to prematurely enter the mitotic phase, leading to mitotic
catastrophe and apoptotic cell death [3]. It is reasonable to propose
that the interaction of SLK and Tpr may control the local concentration
of SLK at speciﬁc subcellular sites, and potentially regulate its local
kinase activity and function in mitosis and cell cycle progression.
Additional studies will be required to verify these possibilities.
We and others have demonstrated that the catalytic activity of SLK is
associated with autophosphorylation [12,14]. In the present study, we
showed that expression of Tpr reduced the global autophosphorylation
of SLK at S189 and T183, implying a reduction in SLK catalytic activity
(Fig. 9). As expected, this reduction in autophosphorylationwas accom-
panied by a reduction in apoptosis (Fig. 9), a well-characterized action
of SLK in kidney and other cells [3,6,10,14], as well as a reduction of
AP-1 activity (Fig. 9) [14]. Partial reduction in phosphorylation likely
reﬂects the fact that only a fraction of the total cellular SLK in cells co-
localized with Tpr (Fig. 7); however, inhibition of SLK signaling by Tpr
appearedmore pronounced, perhaps reﬂecting differences in sensitivity
of the assays. Interestingly, Tpr was recently found to have a role in
regulating the localization of the tumor suppressor gene, p53. Reduction
of Tpr expression led to the accumulation of p53 in the nucleus leading
to p53-dependent promotion of apoptosis and autophagy [40].
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protein (Figs. 4–7). The C-terminal domain of SLK interacted with
endogenous and ectopic α-actinin-4, and more speciﬁcally with the
N-terminal domain of α-actinin-4 (amino acids 1–300) (Fig. 6), a
domain responsible for other protein–protein interactions (see
below). Co-localization of SLK and α-actinin-4 was previously shown
in muscle cells [9], thus providing further support for the interaction
of these two proteins. α-Actinin-4 is one of four α-actinin isomers
[41], and this cytoskeletal protein plays a key role in GEC/podocyte biol-
ogy [21]. In particular, α-actinin-4, is the sole isoform expressed in
human podocytes, and mutations in α-actinin-4 cause familial focal
segmental glomerulosclerosis [21]. α-Actinin-4 belongs to the spectrin
superfamily; it exists in cells as a head-to-tail anti-parallel homodimer
[20,21,41]. The best deﬁned function of α-actinin-4 is to interact with
and crosslink actin ﬁlaments with other proteins through its
N-terminal domain, ultimately increasing cell motility [20,21,41].
These effects are achieved through the actin-binding domain that con-
tains two highly conserved calponin domains. These calponin domains,
termed CH1 and CH2, each contain three actin-binding sites. CH2, in ad-
dition to its actin-binding activity, may play a role in modulating
phosphoinositide-binding, and therefore mediate cytoskeleton remod-
eling [21,41].
PCA and immunoﬂuorescence microscopy demonstrated that
GFP-α-actinin-4-SLK heterodimers were localized mainly in the
cytoplasm and perinuclear regions of COS-1 cells and GECs (Figs. 4
and 7). However, α-actinin-4 ﬂuorescence extended to the cell periph-
ery, whereas SLK ﬂuorescence was located more centrally (Fig. 7A and
B). SLK was demonstrated to participate in cytoskeletal remodeling
and contribute to adhesion site destabilization and turnover during
cell cycle progression [3,8]. Overexpression of SLK induced the disas-
sembly of actin stress ﬁbers, and relocalization of actin to the cell pe-
riphery [8]. These actions of SLK could potentially be accomplished
through its association with α-actinin-4. We did not observe any effect
of α-actinin-4 on the phosphorylation of SLK (Fig. 10), suggesting that
α-actinin-4 serves only as an adaptor protein, which mediates the
interaction of SLKwith other proteins or the actin cytoskeleton. Another
consideration is that SLK alters the phosphorylation and function of
α-actinin-4, including its actin-binding properties. It has been demon-
strated that adoption of an “open” conformation of α-actinin-4 by
mutational disruption of the CH2 domain increases its afﬁnity for actin
[42]. Since SLK can bind to the N-terminus of α-actinin-4, which
contains the CH2 domain, SLKmay inhibit formation of the open confor-
mation of α-actinin-4, and negatively regulate actin binding. Further
studies will be required to conﬁrm this hypothesis. To our knowledge,
there are no reported associations of α-actinin-4 and Tpr, and the two
proteins are most likely interacting with SLK independently.
To provide further evidence for the importance of the SLK coiled-coils
in protein–protein interactions, we introduced pointmutations in hydro-
phobic residues, with the purpose of disrupting the coiled-coil structures
(Fig. 11). All mutations reduced the homodimerization of SLK signiﬁcant-
ly, and the mutation in the NTC disrupted homodimerization more
markedly, compared with the CTC mutations (Fig. 8). Nevertheless, the
mutations did not entirely disrupt the ability of SLK to homodimerize.
Heterodimerization of SLK with α-actinin-4 and Tpr appeared to be less
prominent, compared with homodimerization, and the mutant forms of
SLK showed a complete inability to associate with Tpr or α-actinin-4
(Fig. 8). Possibly, SLK dimerization may be required for interactions of
SLK with α-actinin-4 or Tpr to take place. These results conﬁrm the im-
portance of the C-terminal coiled-coil regions in mediating both homo-
and heterodimerization of SLK, although in case of homodimerization,
other regions of the SLK protein (e.g. catalytic domain) may also be
contributing [12].
In summary, we have demonstrated interactions between SLK and
two proteins, α-actinin-4, and Tpr. The interactions are mediated by
the C-terminal coiled-coil regions of SLK, as point mutations in the SLK
coils reduced both homodimerization and heterodimerization. Tprmodulated the kinase activity and signaling of SLK, supporting the
conclusion that protein–protein interactions may be important in the
functions of SLK, including its role in cell growth and cytoskeletal regu-
lation. The results add to our understanding of the pathophysiological
role of SLK in renal ischemia–reperfusion injury, where apoptosis and
cell proliferation are well-characterized processes, as well as homeosta-
sis and injury in podocytes, a cell type that is exquisitely dependent on
the functioning of α-actinin-4. The results also highlight the degree of
complexity involved in the regulation of SLK activity, which includes
mRNA stabilization, and protein dimerization and phosphorylation
[11,14,43]. Further studies will be required to develop a more complete
understanding of these regulatory factors and their impact on the role of
SLK in organ development and disease.
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